Trial Profile
Phase I single-dose trial of ATI 9242 in volunteers
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 30 Dec 2016
Price :
$35
*
At a glance
- Drugs ATI 9242 (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- Sponsors ARYx Therapeutics
- 02 May 2008 New trial record.